Vildagliptin

DESCRIPTION

A DPP-4 inhibitor (Ki = 0.003 µM); selective for DPP-4 over DPP-2, DPP-8, and DPP-9 (Kis = >500, 0.81, and 0.095 µM, respectively); decreases plasma glucose levels and increases plasma insulin levels during an oral glucose challenge in Zucker fa/fa rats at 3 mg/kg; prevents increases in liver triglyceride and TBARS levels in a mouse model of NAFLD induced by a high-cholesterol diet

DETAILS

Inchi: InChI=1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2/t12?,13?,14?,16-,17-
Purity: ≥98%
Raptas: Product Type|Biochemicals|Antioxidants||Product Type|Biochemicals|Small Molecule Inhibitors|Peptidases & Proteases||Research Area|Cell Biology|Proteolysis|Cytosolic & Secreted Proteases||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Endocrinology & Metabolism|Metabolic Diseases|NAFLD & NASH||Research Area|Immunology & Inflammation||Research Area|Oxidative Stress & Reactive Species|Antioxidant Activity||Research Area|Oxidative Stress & Reactive Species|Lipid Peroxidation
Smiles: O=C(CN[C@@]1(CC(C2)C3)CC3C[C@]2(O)C1)N4[C@H](C#N)CCC4
Inchikey: SYOKIDBDQMKNDQ-QWJLZPNVSA-N
Cas Number: 274901-16-5
Formulation: A crystalline solid
Storage Temp: -20
Shipping Temp: -20
Formula Markup: C17H25N3O2
Formula Weight: 303.4
Shelf Life Days: 1460